Favipiravir shows potential in protecting against Chandipura virus, with preclinical studies showing reduced viral load and improved survival rates.

Preclinical studies by the National Institute of Virology (NIV) reveal that the anti-viral drug Favipiravir may offer significant protection against the Chandipura virus.

Vadodara: Three children died in Panchmahal district and one in Dahod due to viral encephalitis during one week. The latest ...

The Chandipura virus (CHPV) is endemic in central India and symptoms include high fever and seizures. The infection also induces encephalitis. Anti-viral drug Favipiravir has been found to have ...

Indian scientists are developing vaccine and antivirals for Chandipura virus, which causes encephalitis, according to Dr Naveen Kumar, ICMR-NIV Pune Director.

The Chandipura virus (CHPV) is endemic in central India and symptoms include high fever and seizures. The infection also induces encephalitis. PTI Last Updated : 24 June 2025, 01:58 IST Follow Us : ...

By Shalini Bhardwaj Pune (Maharashtra) [India], June 23 (ANI): Indian scientists are developing vaccine and antivirals for Chandipura virus, which causes encephalitis, according to Dr Naveen Kumar ...

The virus that won't quit: New research reveals how SARS-CoV-2 evolves by Kate Burke, University of New South Wales edited by Sadie Harley, reviewed by Robert Egan Editors' notes ...